Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0098 | 1 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0014 | 1 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.00083 | 1 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |